Liothyronine Sodium (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Liothyronine Sodium drug offered from Avera McKennan Hospital. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Liothyronine Sodium |
SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-03-09 |
END MARKETING DATE: | 0000-00-00 |
Liothyronine Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Liothyronine Sodium from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(ug/1) |
START MARKETING DATE: | 2015-03-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0025_98ee10f3-d081-4e03-9350-df87c5a8ab7d |
PRODUCT NDC: | 69189-0025 |
APPLICATION NUMBER: | ANDA200295 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers: